Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia.
Patients with serious psychiatric disorders are frequently treated by primary care physicians, who may have difficulty keeping up with recent advances in psychiatry. This paper presents an updated synopsis for three major psychiatric illnesses: major depression, bipolar disorder, and schizophrenia. Current definitions, updated diagnostic criteria, short- and long-term treatment strategies with algorithms, and special challenges for the clinician are discussed for each of these illnesses. On the basis of each illness's distinct characteristics, five treatment principles are emphasized: 1) Treatment strategies should be long-term and should emphasize adherence, 2) treatment choice should be empirical, 3) combinations of medications may be helpful, 4) a combination of psychosocial and pharmacologic treatments may be more useful than either alone, and 5) the family or "significant others" as well as a consumer organization need to be involved. Some of the new directions in dinical research to refine these strategies and meet these challenges are also described.
Glick
I D
ID
Stanford University School of Medicine, California 94305-5723, USA. iraglick@stanford.edu
Suppes
T
T
DeBattista
C
C
Hu
R J
RJ
Marder
S
S
D000465:Algorithms; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003131:Combined Modality Therapy; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005190:Family; D006801:Humans; D011613:Psychotherapy; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents